Trials / Conditions / Palmar-plantar Erythrodysesthesia

Palmar-plantar Erythrodysesthesia

9 registered clinical trials studyying Palmar-plantar Erythrodysesthesia.

Status	Trial	Sponsor	Phase
Completed	Efficacy and Safety of Moisturising Cream With or Without Vitamin E and Urea Cream in Palmar-plantar Erythrody NCT05939726	Sarawak General Hospital	N/A
Completed	The Topical Application of Vitamin B6 in Palmar-Plantar Erythrodysesthesia NCT02625415	Cyprus University of Technology	N/A
Completed	Treatment of Palmar Plantar Erythrodysesthesia (PPE) With Topical Sildenafil NCT01219023	Duke University	Phase 1
Completed	Study of 0.1% Uracil Topical Cream (UTC) for the Prevention of Hand-Foot Syndrome NCT01100463	Nanometics (d.b.a. PHD Biosciences)	Phase 1 / Phase 2
Completed	F511 Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Doxorubicin Hydrochloride Lip NCT00992706	Swiss Cancer Institute	Phase 3
Terminated	Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Brea NCT00751101	University of California, San Francisco	Phase 2
Terminated	Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer NCT00486213	National Cancer Centre, Singapore	Phase 3
Completed	Topical Antiperspirant for Hand-Foot Syndrome NCT00213993	University of Wisconsin, Madison	Phase 2
Unknown	Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal NCT00559858	Cambridge University Hospitals NHS Foundation Trust	Phase 3